TOTAL ASR ACET IMP SIZE 54
Report
- Report Number
- 1818910-2014-24294
- Event Type
- Injury
- Date Received
- July 28, 2014
- Date of Event
- August 23, 2012
- Report Date
- July 17, 2014
- Manufacturer
- DEPUY INTERNATIONAL LTD. 8010379
- Product Code
- KWA
- Removal / Correction Number
- Z-1749/1816-2011
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- PATIENT
Narratives
ADDITIONAL NARRATIVE:IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.NO 510(K) NUMBER PROVIDED BECAUSE THIS IMPLANT IS SOLD INTERNATIONALLY WITH DIFFERENT INDICATIONS FOR USE; IT IS CURRENTLY SOLD IN THE US UNDER A DIFFERENT PART NUMBER. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.
NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER DINT (B)(4) REASON FOR ORIGINAL COMPLAINT ¿ASR REVISION TO TAKE PLACE (B)(6) 2012.ASR RESURFACING (LEFT).REASON(S) FOR REVISION: UNKNOWN.PATIENT IS BI-LATERAL. THIS DINT IS FOR THE LEFT HIP REVISION. FOR THE RIGHT HIP REVISION PLEASE SEE DINT (B)(4). UPDATE - ADDED REASON FOR REVISON, REVISON DATE AND BI-LATERAL COMMENT. TAKEN FROM CLAIMSUITE DATED (B)(6) 2014.REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION.FOR RIGHT SIDE SEE COM (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 439227 | TOTAL ASR ACET IMP SIZE 54 | HIP ACETABULAR CUP | KWA | DEPUY INTERNATIONAL LTD. 8010379 | 2071550 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |